secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRONWOOD PHARMACEUTICALS INC (IRWD)
CIK:        0001446847
Form:       8-K
Filed at:   2023-06-30T23:59:59+00:00
Accession:  0001104659-23-077076
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ironwood completes $1.15B tender offer for VectivBio, acquires ~97.6% of shares
-------------------------------------------------------------------------------

- Tendered 59.3M shares represent ~94.4% plus 2.0M via guaranteed delivery (~97.6% total).
- Offer price $17/share cash; total consideration ~$1.15B.
- Borrowed $400M under Revolving Credit Agreement to fund portion.
- Plans to delist VectivBio shares from Nasdaq and execute Swiss squeeze-out merger.
- Ironwood appointed new directors to VectivBio board effective immediately.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446847/000110465923077076/0001104659-23-077076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446847/000110465923077076/tm2320339d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-077076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer